Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation.
Ceruloplasmin (CP) effectively inhibited superoxide and ferritin-dependent peroxidation of phospholipid liposomes, using xanthine oxidase or gamma irradiation of water as sources of superoxide. In addition, CP inhibited superoxide-dependent mobilization of iron from ferritin, suggesting that CP inhibited lipid peroxidation by decreasing the availability of iron from ferritin. CP also exhibited some superoxide scavenging activity as evidenced by its inhibition of superoxide-dependent cytochrome c reduction. However, superoxide scavenging by CP did not quantitatively account for its inhibitory effects on iron release. The effects of CP on iron-catalyzed lipid peroxidation in systems containing exogenously added ferrous iron was also investigated. CP exhibited prooxidant and antioxidant effects; CP stimulated at lower concentrations, reached a maximum, and inhibited at higher concentrations. However, the addition of apoferritin inhibited CP and Fe(II)-catalyzed lipid peroxidation at all concentrations of CP. In addition, CP catalyzed the incorporation of Fe(II) into apoferritin. Collectively these data suggest that CP inhibits superoxide and ferritin-dependent lipid peroxidation via its ability to incorporate reductively-mobilized iron into ferritin.
Samokyszyn
V M
VM
Biotechnology Center, Utah State University, Logan 84332-4430.
Reif
D W
DW
Miller
D M
DM
Aust
S D
SD
D000818:Animals; D001052:Apoferritins / Q000378:metabolism; D002570:Ceruloplasmin / Q000494:pharmacology*; D005293:Ferritins / Q000187:drug effects*; D007501:Iron / Q000378:metabolism*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013481:Superoxides / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D013481:Superoxides; D005293:Ferritins; D001052:Apoferritins; D007501:Iron; D002570:Ceruloplasmin